GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +11 | 93.68M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | — |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | — | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | — | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | — |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | — | 24.13M | $697.01M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasivo) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasivo) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 2.14M | — | $61.67M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 1.82M | — | $52.42M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (pasivo) | 1.38M | — | $39.96M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 814.52K | — | $23.52M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | ARK Investment Management ✦ | 453.59K | — | $13.10M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 299.80K | — | $8.66M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 84.75K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | PRIMECAP Management ✦ | 66.18K | — | $1.91M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 20.20K | — | $583,405 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 481 tenedores, 137.05M acciones, $11.53B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 20.89K acc. · $3.53M
Officer, Director · 7.59K acc. · $1.29M
Officer, Director · 9.02K acc. · $1.52M
Director · 116 acc. · $18,148
Officer · 13.25K acc. · $2.20M
Officer · 3.70K acc. · $605,286
Officer · 9.93K acc. · $1.63M
Officer · 19.01K acc. · $3.14M
Officer · 400 acc. · $67,168
Officer · 3.46K acc. · $579,639
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología